125 related articles for article (PubMed ID: 22992863)
21. Synergistic antitumor effect mediated by a paclitaxel-conjugated polymeric micelle-coated oncolytic adenovirus.
Kasala D; Lee SH; Hong JW; Choi JW; Nam K; Chung YH; Kim SW; Yun CO
Biomaterials; 2017 Nov; 145():207-222. PubMed ID: 28869866
[TBL] [Abstract][Full Text] [Related]
22. Rejection of adenovirus infection is independent of coxsackie and adenovirus receptor expression in cisplatin-resistant human lung cancer cells.
Zhang NH; Peng RQ; Ding Y; Zhang XS
Oncol Rep; 2016 Aug; 36(2):715-20. PubMed ID: 27373420
[TBL] [Abstract][Full Text] [Related]
23. An oncolytic adenovirus vector combining enhanced cell-to-cell spreading, mediated by the ADP cytolytic protein, with selective replication in cancer cells with deregulated wnt signaling.
Toth K; Djeha H; Ying B; Tollefson AE; Kuppuswamy M; Doronin K; Krajcsi P; Lipinski K; Wrighton CJ; Wold WS
Cancer Res; 2004 May; 64(10):3638-44. PubMed ID: 15150123
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel resistance increases oncolytic adenovirus efficacy via upregulated CAR expression and dysfunctional cell cycle control.
Ingemarsdotter CK; Tookman LA; Browne A; Pirlo K; Cutts R; Chelela C; Khurrum KF; Leung EY; Dowson S; Webber L; Khan I; Ennis D; Syed N; Crook TR; Brenton JD; Lockley M; McNeish IA
Mol Oncol; 2015 Apr; 9(4):791-805. PubMed ID: 25560085
[TBL] [Abstract][Full Text] [Related]
25. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.
Ma S; Qu W; Mao L; Zhu Z; Jia L; Zhao L; Zheng X
Oncol Rep; 2012 May; 27(5):1443-50. PubMed ID: 22294034
[TBL] [Abstract][Full Text] [Related]
26. A double-regulated oncolytic adenovirus with improved safety for adenocarcinoma therapy.
Wei N; Fan JK; Gu JF; He LF; Tang WH; Cao X; Liu XY
Biochem Biophys Res Commun; 2009 Oct; 388(2):234-9. PubMed ID: 19653996
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of increased coxsackie and adenovirus receptor gene expression and adenovirus uptake by phytoestrogen and histone deacetylase inhibitor in human bladder cancer cells and the potential clinical application.
Pong RC; Roark R; Ou JY; Fan J; Stanfield J; Frenkel E; Sagalowsky A; Hsieh JT
Cancer Res; 2006 Sep; 66(17):8822-8. PubMed ID: 16951199
[TBL] [Abstract][Full Text] [Related]
28. [Abscopal effect on metastatic tumor induced by oncolytic virus of H101 combining with local heating].
Hu F; Hu XH; Yu P; Zhang JX; Lou GG; Liu HL; Wu B; Zhao RH; Xia HQ; Wang Y; Chen J; Ben Y; Chen SY
Ai Zheng; 2006 Aug; 25(8):919-24. PubMed ID: 16965669
[TBL] [Abstract][Full Text] [Related]
29. Enhanced therapeutic efficacy of an adenovirus-PEI-bile-acid complex in tumors with low coxsackie and adenovirus receptor expression.
Lee CH; Kasala D; Na Y; Lee MS; Kim SW; Jeong JH; Yun CO
Biomaterials; 2014 Jul; 35(21):5505-16. PubMed ID: 24731708
[TBL] [Abstract][Full Text] [Related]
30. Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models.
Wu CL; Shieh GS; Chang CC; Yo YT; Su CH; Chang MY; Huang YH; Wu P; Shiau AL
Clin Cancer Res; 2008 Feb; 14(4):1228-38. PubMed ID: 18281558
[TBL] [Abstract][Full Text] [Related]
31. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
32. PED/PEA-15 modulates coxsackievirus-adenovirus receptor expression and adenoviral infectivity via ERK-mediated signals in glioma cells.
Botta G; Perruolo G; Libertini S; Cassese A; Abagnale A; Beguinot F; Formisano P; Portella G
Hum Gene Ther; 2010 Sep; 21(9):1067-76. PubMed ID: 20406097
[TBL] [Abstract][Full Text] [Related]
33. Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines.
Huang X; Jia R; Zhao X; Liu B; Wang H; Wang J; Zhou Y; Cun B; Ge S; Fan X
Br J Ophthalmol; 2012 Oct; 96(10):1331-8. PubMed ID: 22843987
[TBL] [Abstract][Full Text] [Related]
34. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
35. Conditionally replicating adenovirus improves gene replication efficiency and anticancer effect of E1-deleted adenovirus carrying TRAIL in head and neck squamous cell carcinoma.
Shim SH; Lee CT; Hun Hah J; Lee JJ; Park SW; Heo DS; Sung MW
Cancer Sci; 2010 Feb; 101(2):482-7. PubMed ID: 19922505
[TBL] [Abstract][Full Text] [Related]
36. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
Ye X; Lu Q; Zhao Y; Ren Z; Ren XW; Qiu QH; Tong Y; Liang M; Hu F; Chen HZ
Int J Mol Med; 2005 Dec; 16(6):1179-84. PubMed ID: 16273304
[TBL] [Abstract][Full Text] [Related]
37. In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL.
El-Zawahry A; Lu P; White SJ; Voelkel-Johnson C
Cancer Gene Ther; 2006 Mar; 13(3):281-9. PubMed ID: 16167063
[TBL] [Abstract][Full Text] [Related]
38. Dual tumor targeting with pH-sensitive and bioreducible polymer-complexed oncolytic adenovirus.
Moon CY; Choi JW; Kasala D; Jung SJ; Kim SW; Yun CO
Biomaterials; 2015 Feb; 41():53-68. PubMed ID: 25522965
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.
Anders M; Christian C; McMahon M; McCormick F; Korn WM
Cancer Res; 2003 May; 63(9):2088-95. PubMed ID: 12727824
[TBL] [Abstract][Full Text] [Related]
40. Safety profiles and antitumor efficacy of oncolytic adenovirus coated with bioreducible polymer in the treatment of a CAR negative tumor model.
Jung SJ; Kasala D; Choi JW; Lee SH; Hwang JK; Kim SW; Yun CO
Biomacromolecules; 2015 Jan; 16(1):87-96. PubMed ID: 25400213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]